← Leaderboards
Scott E Kern
Johns Hopkins University
$10,982,210
Attributed
$10,982,210
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.7M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$49,570,666 · 14
By mechanism
P50$43,600,759 · 10
R01$4,466,983 · 3
P01$1,502,924 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Alison P Klein$15,423,583
- Donald S. Burke$42,062,956
- Nancy E Davidson$32,860,580
- Argye E. Hillis$28,779,519
- Barbara Landau$2,123,211
Others in their field
Top investigators on “Malignant Neoplasm Of Pancreas”
- David Heimbrook · Leidos Biomedical Research, Inc.$73,277,592
- Anirban Maitra · Johns Hopkins University$43,028,398
- Walter John Curran · Thomas Jefferson University$26,641,549
- Surinder Kumar Batra · University Of Pittsburgh At Pittsburgh$26,074,679
- Michael A Hollingsworth · University Of Nebraska Medical Center$23,837,917
- Robert E Reiter · University Of California Los Angeles$21,473,394
Research focus
Malignant Neoplasm Of PancreasFundingProgramsResearch PersonnelPancreas NeoplasmsNeoplasm /Cancer GeneticsMalignant Neoplasm Of Gastrointestinal TractDesignPublicationsMalignant NeoplasmsBaseMedicalInstitutionTumorCareer DevelopmentTumor Suppressor GenesFutureGene MutationGenesMutationCareerMutateIncidenceBrca2 Gene
Grant awards (87)
Career Enhancement Program$119,324
P50 · FY2022 · CA · contact PI
Career Enhancement Program$105,606
P50 · FY2021 · CA · contact PI
Career Enhancement Program$121,890
P50 · FY2020 · CA · contact PI
Career Enhancement Program$119,324
P50 · FY2019 · CA · contact PI
Career Enhancement Program$128,306
P50 · FY2018 · CA · contact PI
Administration and Communication$121,107
P50 · FY2016 · CA · contact PI
Career Program$94,411
P50 · FY2016 · CA · contact PI
Administration and Communication$130,391
P50 · FY2015 · CA · contact PI
Career Program$101,649
P50 · FY2015 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,162,002
P50 · FY2014 · CA · contact PI
Administration and Communication$129,331
P50 · FY2014 · CA · contact PI
Career Program$100,824
P50 · FY2014 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,150,501
P50 · FY2013 · CA · contact PI
Discovery and Evaluation of Prioritized Mutations in Pancreatic Cancer$329,349
P01 · FY2013 · CA · contact PI
Administration and Communication$128,645
P50 · FY2013 · CA · contact PI
Career Program$100,288
P50 · FY2013 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,300,000
P50 · FY2012 · CA · contact PI
Discovery and Evaluation of Prioritized Mutations in Pancreatic Cancer$290,641
P01 · FY2012 · CA · contact PI
High-throughput analysis of pancreatic cancer mutations$247,571
R01 · FY2012 · CA · contact PI
Administration and Communication$137,588
P50 · FY2012 · CA · contact PI
Career Program$107,261
P50 · FY2012 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,185,000
P50 · FY2011 · CA · contact PI
Fanconi Defects in Pancreatic Cancer Oncogenesis$297,083
R01 · FY2011 · CA · contact PI
Discovery and Evaluation of Prioritized Mutations in Pancreatic Cancer$291,304
P01 · FY2011 · CA · contact PI
Pharmacodiagnotics through Molecular Clues$248,715
P50 · FY2011 · CA · contact PI
High-throughput analysis of pancreatic cancer mutations$247,569
R01 · FY2011 · CA · contact PI
Administration and Communication Core$129,634
P50 · FY2011 · CA · contact PI
Career Development Program$106,785
P50 · FY2011 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,300,000
P50 · FY2010 · CA · contact PI
Fanconi Defects in Pancreatic Cancer Oncogenesis$306,270
R01 · FY2010 · CA · contact PI
Discovery and Evaluation of Prioritized Mutations in Pancreatic Cancer$300,431
P01 · FY2010 · CA · contact PI
Pharmacodiagnotics through Molecular Clues$262,958
P50 · FY2010 · CA · contact PI
High-throughput analysis of pancreatic cancer mutations$255,225
R01 · FY2010 · CA · contact PI
Administration and Communication Core$136,315
P50 · FY2010 · CA · contact PI
Career Development Program$114,774
P50 · FY2010 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,300,000
P50 · FY2009 · CA · contact PI
Fanconi Defects in Pancreatic Cancer Oncogenesis$306,270
R01 · FY2009 · CA · contact PI
Discovery and Evaluation of Prioritized Mutations in Pancreatic Cancer$291,199
P01 · FY2009 · CA · contact PI
Pharmacodiagnotics through Molecular Clues$264,273
P50 · FY2009 · CA · contact PI
High-throughput analysis of pancreatic cancer mutations$255,225
R01 · FY2009 · CA · contact PI
Administration and Communication Core$136,267
P50 · FY2009 · CA · contact PI
Career Development Program$117,259
P50 · FY2009 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,300,000
P50 · FY2008 · CA · contact PI
Fanconi Defects in Pancreatic Cancer Oncogenesis$306,270
R01 · FY2008 · CA · contact PI
Pharmacodiagnotics through Molecular Clues$273,477
P50 · FY2008 · CA · contact PI
Administration and Communication Core$135,745
P50 · FY2008 · CA · contact PI
Career Development Program$119,357
P50 · FY2008 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,457,370
P50 · FY2007 · CA · contact PI
Supplement: Screening for Early Pancreatic Neoplasia: A Multi-Center Study$281,402
P50 · FY2007 · CA · contact PI
Pharmacodiagnotics through Molecular Clues$257,979
P50 · FY2007 · CA · contact PI
Administration and Communication Core$127,778
P50 · FY2007 · CA · contact PI
Career Development Program$115,318
P50 · FY2007 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,548,368
P50 · FY2006 · CA · contact PI
DPC4, target of 18q deletion in pancreatic cancer$319,714
R01 · FY2006 · CA · contact PI
SPORE in Gastrointestinal Cancer$250,000
P50 · FY2006 · CA · contact PI
SPORE in Gastrointestinal Cancer$200,000
P50 · FY2006 · CA · contact PI
SPORE in Gastrointestinal Cancer$75,200
P50 · FY2006 · CA · contact PI
SPORE in Gastrointestinal Cancer$2,610,433
P50 · FY2005 · CA
DPC4, target of 18q deletion in pancreatic cancer$327,409
R01 · FY2005 · CA
SPORE in Gastrointestinal Cancer$75,185
P50 · FY2005 · CA
SPORE in Gastrointestinal Cancer$2,592,792
P50 · FY2004 · CA
DPC4, target of 18q deletion in pancreatic cancer$327,409
R01 · FY2004 · CA
SPORE in Gastrointestinal Cancer$75,112
P50 · FY2004 · CA
SPORE in Gastrointestinal Cancer$2,788,126
P50 · FY2003 · CA
DPC4, target of 18q deletion in pancreatic cancer$327,409
R01 · FY2003 · CA
SPORE in Gastrointestinal Cancer$73,653
P50 · FY2003 · CA
SPORE in Gastrointestinal Cancer$2,606,130
P50 · FY2002 · CA
SPORE IN GASTROINTESTINAL CANCER$1,242,878
P50 · FY2002 · CA
DPC4, target of 18q deletion in pancreatic cancer$327,409
R01 · FY2002 · CA
Components of Early and Late Pancreatic Neoplasia$0
P50 · FY2002 · CA
TARGETS FOR SCREENING IN PANCREATIC NEOPLASIA$0
P50 · FY2002 · CA
NEW GENETIC CLUES FOR PANCREATIC CANCER$0
P50 · FY2002 · CA
NEW GENETIC MARKERS FOR PANCREATIC CANCER$0
P50 · FY2002 · CA
SPORE IN GASTROINTESTINAL CANCER$2,485,530
P50 · FY2001 · CA
DPC4 TARGET OF 18Q HOMOZYGOUS DELETIONS IN PANCREATIC CA$312,628
R01 · FY2001 · CA
SPORE IN GASTROINTESTINAL CANCER$209,540
P50 · FY2001 · CA
SPORE IN GASTROINTESTINAL CANCER$187,500
P50 · FY2001 · CA
TARGETS FOR SCREENING IN PANCREATIC NEOPLASIA$0
P50 · FY2001 · CA
NEW GENETIC MARKERS FOR PANCREATIC CANCER$0
P50 · FY2001 · CA
TARGETS FOR SCREENING IN PANCREATIC NEOPLASIA$0
P50 · FY2001 · CA
NEW GENETIC MARKERS FOR PANCREATIC CANCER$0
P50 · FY2001 · CA
TARGETS FOR SCREENING IN PANCREATIC NEOPLASIA$0
P50 · FY2001 · CA
NEW GENETIC MARKERS FOR PANCREATIC CANCER$0
P50 · FY2001 · CA
SPORE IN GASTROINTESTINAL CANCER$2,413,136
P50 · FY2000 · CA
DPC4 TARGET OF 18Q HOMOZYGOUS DELETIONS IN PANCREATIC CA$303,522
R01 · FY2000 · CA
TARGETS FOR SCREENING IN PANCREATIC NEOPLASIA$219,161
P50 · FY2000 · CA
NEW GENETIC MARKERS FOR PANCREATIC CANCER$219,161
P50 · FY2000 · CA